Search

Your search keyword '"Mahony, James B."' showing total 46 results

Search Constraints

Start Over You searched for: Author "Mahony, James B." Remove constraint Author: "Mahony, James B." Database MEDLINE Remove constraint Database: MEDLINE
46 results on '"Mahony, James B."'

Search Results

2. Enumeration of Viable Chlamydia from Infected Animals Using Immunofluorescent Microscopy.

3. Low-cost and versatile integration of microwire electrodes and optical waveguides into silicone elastomeric devices using modified xurographic methods.

4. Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

5. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge.

6. Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein.

7. Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.

8. Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infection.

9. Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803.

10. Molecular diagnosis of respiratory virus infections.

11. Prognosis of West Nile virus associated acute flaccid paralysis: a case series.

12. Evaluation and clinical validation of an alcohol-based transport medium for preservation and inactivation of respiratory viruses.

13. Expectant management versus immediate treatment for low-grade cervical intraepithelial neoplasia : a randomized trial in Canada and Brazil.

14. Chlamydia Pneumoniae CdsL Regulates CdsN ATPase Activity, and Disruption with a Peptide Mimetic Prevents Bacterial Invasion.

15. Development of a novel bead-based multiplex PCR assay for combined subtyping and oseltamivir resistance genotyping (H275Y) of seasonal and pandemic H1N1 influenza A viruses.

16. Nucleic acid amplification-based diagnosis of respiratory virus infections.

17. Development and evaluation of a flocked nasal midturbinate swab for self-collection in respiratory virus infection diagnostic testing.

18. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening.

19. Interactions between flagellar and type III secretion proteins in Chlamydia pneumoniae.

20. Difficulty with mumps diagnosis: what is the contribution of mumps mimickers?

21. A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

22. Cost analysis of multiplex PCR testing for diagnosing respiratory virus infections.

23. Risk factors and viruses associated with hospitalization due to lower respiratory tract infections in Canadian Inuit children : a case-control study.

24. Multiplex PCR tests sentinel the appearance of pandemic influenza viruses including H1N1 swine influenza.

25. Detection of respiratory viruses by molecular methods.

26. Characterization of the putative type III secretion ATPase CdsN (Cpn0707) of Chlamydophila pneumoniae.

27. Asthma management by monitoring sputum neutrophil count.

28. Interactions between CdsD, CdsQ, and CdsL, three putative Chlamydophila pneumoniae type III secretion proteins.

29. Chlamydophila pneumoniae PknD exhibits dual amino acid specificity and phosphorylates Cpn0712, a putative type III secretion YscD homolog.

30. Issues for reporting results.

31. The clinical need for the RVP test.

32. The pathogens.

33. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

34. Molecular diagnosis of severe acute respiratory syndrome: the state of the art.

35. Interobserver agreement in the interpretation of anal intraepithelial neoplasia.

36. Severe acute respiratory syndrome coronavirus nucleocapsid protein expressed by an adenovirus vector is phosphorylated and immunogenic in mice.

37. Combining human papillomavirus testing or cervicography with cytology to detect cervical neoplasia.

38. Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus.

39. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities: a randomized trial and economic evaluation.

40. Incidence, clearance and predictors of human papillomavirus infection in women.

41. Chlamydiae host cell interactions revealed using DNA microarrays.

42. Prevalence of infection with carcinogenic human papillomavirus among older women.

43. Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

44. Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients.

45. Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells.

46. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis.

Catalog

Books, media, physical & digital resources